Arewa O P, Nahirniak S, Clarke G
Department of Laboratory Medicine & Blood Bank, Arar Central Hospital, Arar, Saudi Arabia.
Department of Laboratory Medicine & Pathology, University of Alberta Hospital, Edmonton, AB, Canada.
Case Rep Med. 2013;2013:568364. doi: 10.1155/2013/568364. Epub 2014 Jan 16.
Posttransfusion purpura (PTP) is an uncommon, but potentially fatal, transfusion reaction characterized by profound thrombocytopenia and bleeding. PTP is caused by alloimmunization to human platelet specific antigens following blood component transfusion. Although there is evidence of a wide serological spectrum of culprit antibodies implicated, Anti-human-platelet-antigen- (HPA-) 1a is the most common antibody in cases reported. We report a case of posttransfusion purpura in an African American. The patient was negative for HPA-1a antibodies, but anti-HPA-1b was identified with a platelet phenotype of HPA-1a/HPA-1a. Although less common, HPA-1b antibody may be an important consideration in posttransfusion purpura diagnosed in patients of African descent.
输血后紫癜(PTP)是一种罕见但可能致命的输血反应,其特征为严重血小板减少和出血。PTP是由于输血后对人类血小板特异性抗原产生同种免疫所致。尽管有证据表明涉及多种血清学类型的致病抗体,但在报告的病例中,抗人血小板抗原(HPA)-1a是最常见的抗体。我们报告了一例非裔美国人的输血后紫癜病例。该患者HPA-1a抗体阴性,但检测到抗HPA-1b,血小板表型为HPA-1a/HPA-1a。尽管不太常见,但HPA-1b抗体可能是诊断非裔血统患者输血后紫癜时的一个重要考虑因素。